tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SDZXF Stock Latest News

Sandoz confirms E.C. granted marketing authorization for Ranluspec
The FlySandoz confirms E.C. granted marketing authorization for Ranluspec
20h ago
Sandoz wins EU approval for Ranluspec biosimilar, bolstering ophthalmology push
PremiumCompany Announcements
Sandoz wins EU approval for Ranluspec biosimilar, bolstering ophthalmology push
21h ago
Sandoz receives U.S. FDA approval to expand Enzeevu label
PremiumThe Fly
Sandoz receives U.S. FDA approval to expand Enzeevu label
6d ago
Sandoz Wins Expanded U.S. FDA Label for Enzeevu Retinal Biosimilar
PremiumCompany Announcements
Sandoz Wins Expanded U.S. FDA Label for Enzeevu Retinal Biosimilar
6d ago
Sandoz upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Sandoz upgraded to Buy from Hold at Jefferies
12d ago
Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
PremiumThe FlySandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
1M ago
Sandoz price target raised to CHF 55 from CHF 49 at Berenberg
Premium
The Fly
Sandoz price target raised to CHF 55 from CHF 49 at Berenberg
1M ago
Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
Premium
The Fly
Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
1M ago
Sandoz Wins EU Approval for Ondibta Biosimilar Insulin, Bolstering Diabetes Push
PremiumCompany Announcements
Sandoz Wins EU Approval for Ondibta Biosimilar Insulin, Bolstering Diabetes Push
1M ago
Sandoz Targets ‘Golden Decade’ as Patent Cliff Opens USD 600 Billion Generics and Biosimilars Opportunity
PremiumCompany Announcements
Sandoz Targets ‘Golden Decade’ as Patent Cliff Opens USD 600 Billion Generics and Biosimilars Opportunity
1M ago
Sandoz price target raised to CHF 70 from CHF 55 at Barclays
PremiumThe Fly
Sandoz price target raised to CHF 70 from CHF 55 at Barclays
2M ago
Sandoz initiated with a Neutral at Oddo BHF
PremiumThe Fly
Sandoz initiated with a Neutral at Oddo BHF
2M ago
Sandoz’s New Asthma Treatment Study: A Potential Game-Changer?
PremiumCompany AnnouncementsSandoz’s New Asthma Treatment Study: A Potential Game-Changer?
2M ago
SDZXF
Sandoz Strengthens Biosimilars Leadership with Key Acquisition
Premium
Company Announcements
Sandoz Strengthens Biosimilars Leadership with Key Acquisition
3M ago
Sandoz Launches Denosumab Biosimilars in Europe to Expand Affordable Treatment Options
Premium
Company Announcements
Sandoz Launches Denosumab Biosimilars in Europe to Expand Affordable Treatment Options
3M ago
Sandoz Expands European Market with Afqlir® Launch for Retinal Diseases
PremiumCompany Announcements
Sandoz Expands European Market with Afqlir® Launch for Retinal Diseases
3M ago
Sandoz price target raised to CHF 60 from CHF 55 at Deutsche Bank
PremiumThe Fly
Sandoz price target raised to CHF 60 from CHF 55 at Deutsche Bank
3M ago
Sandoz Launches First FDA-Approved MS Biosimilar in US
PremiumCompany Announcements
Sandoz Launches First FDA-Approved MS Biosimilar in US
3M ago
Sandoz Expands Oncology Portfolio with Global License for Pertuzumab Biosimilar
PremiumCompany Announcements
Sandoz Expands Oncology Portfolio with Global License for Pertuzumab Biosimilar
3M ago
Sandoz price target raised to CHF 60 from CHF 55 at JPMorgan
PremiumThe FlySandoz price target raised to CHF 60 from CHF 55 at JPMorgan
4M ago
Evotec to sell Just – Evotec Biologics EU, license technology to Sandoz
Premium
The Fly
Evotec to sell Just – Evotec Biologics EU, license technology to Sandoz
4M ago
EVO
Sandoz Expands Biosimilar Capabilities with Just-Evotec Acquisition
Premium
Company Announcements
Sandoz Expands Biosimilar Capabilities with Just-Evotec Acquisition
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >